11C-Acetate Positron Emission Tomography Imaging and Image Fusion With Computed Tomography and Magnetic Resonance Imaging in Patients With Recurrent Prostate Cancer
Author(s) -
Stefan De Wachter,
Sandra Tomek,
Amir Kurtaran,
Natascha Wachter-Gerstner,
Bob Djavan,
Alexander Becherer,
Markus Mitterhauser,
Georg Dobrozemsky,
Shuren Li,
Richard Pötter,
Robert Dudczak,
Kurt Kletter
Publication year - 2006
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2005.03.5279
Subject(s) - medicine , magnetic resonance imaging , positron emission tomography , computed tomography laser mammography , prostate cancer , preclinical imaging , positron emission tomography computed tomography , nuclear medicine , computed tomography , magnetic resonance spectroscopic imaging , image fusion , tomography , radiology , positron emission , nuclear magnetic resonance , cancer , fusion , in vivo , physics , linguistics , philosophy , microbiology and biotechnology , biology
To assess the clinical value of computed tomography (CT) and magnetic resonance imaging (MRI) image fusion with 11C-acetate (AC) positron emission tomography (PET) imaging for detection and exact location of clinically occult recurrences.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom